|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Pulmonary Medicine, University Hospital Vrije Universiteit Amsterdam, The Netherlands.
Correspondence to: Tom G. Sutedja, MD, PhD, FCCP, Department of Pulmonary Medicine, University Hospital Vrije Universiteit Amsterdam, PO Box 7057, 1007 MB Amsterdam, The Netherlands; e-mail: tg.sutedja{at}azvu.nl
Study objective: To evaluate the cost effectiveness of the Nd-YAG laser and bronchoscopic electrocautery for palliation in patients with symptomatic tumor obstruction.
Design: A retrospective study.
Setting: Bronchoscopy unit of a university hospital.
Patients and intervention: Thirty-one consecutive patients with inoperable non-small cell lung cancer and symptomatic intraluminal tumor underwent bronchoscopic treatment. Dyspnea relief was the primary goal of treatment. Fourteen patients were treated with the Nd-YAG laser and 17 patients with electrocautery.
Measurements and results: Improvement of symptoms was achieved in 70% of patients treated by either Nd-YAG laser or electrocautery. Mean ± SD survival was 8.0 ± 2.5 months after Nd-YAG laser treatment and 11.5 ± 3.5 months after electrocautery. The number of treatment sessions per patient was comparable: Nd-YAG laser, 1.1; electrocautery, 1.2. Duration of hospital stay was longer in patients treated with the Nd-YAG laser (8.4 vs 6.7 days). Average treatment costs, including admission charges, were $5,321 for the Nd-YAG laser and $4,290 for electrocautery. Higher costs in the group treated with the Nd-YAG laser were caused by a longer hospital stay before bronchoscopic treatment. Costs of equipment (electrocautery $6,701 and Nd-YAG laser $208,333), write-offs, maintenance, and repair were not included in this calculation.
Conclusion: Bronchoscopic electrocautery is equally effective but is a less expensive and, in our hospital, a more accessible modality than the Nd-YAG laser for symptomatic palliation of patients with intraluminal airway obstruction.
Key Words: bronchoscopic electrocautery bronchoscopic treatment cost effectiveness Nd-YAG laser
This article has been cited by other articles:
![]() |
P. A. Kvale Chronic Cough Due to Lung Tumors: ACCP Evidence-Based Clinical Practice Guidelines Chest, January 1, 2006; 129(1_suppl): 147S - 153S. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Asimakopoulos, J. Beeson, J. Evans, and M. O. Maiwand Cryosurgery for Malignant Endobronchial Tumors: Analysis of Outcome Chest, June 1, 2005; 127(6): 2007 - 2014. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.F. Beamis, H.D. Becker, S. Cavaliere, H. Colt, J.P. Diaz-Jimenez, J.F. Dumon, E. Edell, K.L. Kovitz, H.N. Macha, A.C. Mehta, et al. ERS/ATS statement on interventional pulmonology: Chairmen: C.T. Bolliger, P.N. Mathur Eur. Respir. J., February 1, 2002; 19(2): 356 - 373. [Full Text] [PDF] |
||||
![]() |
T. D. Coulter and A. C. Mehta The Heat Is On : Impact of Endobronchial Electrosurgery on the Need for Nd-YAG Laser Photoresection Chest, August 1, 2000; 118(2): 516 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Hooper and T. G. Sutedja Electrocautery in Endobronchial Therapy Chest, June 1, 2000; 117(6): 1820 - 1821. [Full Text] [PDF] |
||||
![]() |
T. J. M. van Boxem, J. Westerga, B. J. W. Venmans, P. E. Postmus, and T. G. Sutedja Tissue Effects of Bronchoscopic Electrocautery: Bronchoscopic Appearance and Histologic Changes of Bronchial Wall After Electrocautery Chest, March 1, 2000; 117(3): 887 - 891. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |